Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities
Armenia - Press Releases
- 7341 Press Releases ยท
- RSS
Published on Mon 24 Mar 2025 9:03:08 UTC
NEW YORK, March 24, 2025 /PRNewswire/ -- COSRX, the TikTok-viral K-Beauty brand celebrated for its effective and affordable skincare solutions, has hit a major milestone as its consumer-first skincare bundles, claim top spots on Amazon US. This achievement highlights COSRX's dedication to addressing real skincare needs by offering curated solutions designed to enhance customer experience and deliver greater value.
Published on Mon 24 Mar 2025 9:03:06 UTC
SINGAPORE, March 24, 2025 /PRNewswire/ -- GlobeTeleservices Pte. Ltd. (GTS), a leading global telecom solutions provider, has successfully signed a 3-year exclusivity contract with CelcomDigi, Malaysia's largest mobile network operator (MNO). This partnership aims to enhance secure messaging services for CelcomDigi across the globe, ensuring a better experience for all its subscribers.
Published on Mon 24 Mar 2025 9:02:53 UTC
SINGAPORE, March 24, 2025 /PRNewswire/ -- GlobeTeleservices Pte. Ltd. (GTS), a leading global telecom solutions provider, has successfully signed a 3-year exclusivity contract with CelcomDigi, Malaysia's largest mobile network operator (MNO). This partnership aims to enhance secure messaging services for CelcomDigi across the globe, ensuring a better experience for all its subscribers.
Published on Mon 24 Mar 2025 9:02:01 UTC
Software developed in Japan is fully customizable from set-up through operation and is available viaGitHub
Published on Mon 24 Mar 2025 9:01:59 UTC
STOCKHOLM, March 24, 2025 /PRNewswire/ -- Securitas has completed the divestment of the airport security business in France to local management. Full year 2024 sales were approximately BSEK 1.5 with an operating margin well below average in Securitas Europe.
Published on Mon 24 Mar 2025 8:59:23 UTC
STOCKHOLM, March 24, 2025 /PRNewswire/ -- Securitas has completed the divestment of the airport security business in France to local management. Full year 2024 sales were approximately BSEK 1.5 with an operating margin well below average in Securitas Europe.
Published on Fri 21 Mar 2025 12:11:03 UTC
SHANGHAI and HONG KONG, March 21, 2025 /PRNewswire/ --Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2024, along with several significant milestones achieved in recent months.
Published on Fri 21 Mar 2025 12:10:40 UTC
The Company reaffirms previously provided preliminary financial results for the quarter and full year ended December 31, 2024, and continues to expect regulatory decisions on DrugSorb-ATR marketing applications in 2025
Published on Fri 21 Mar 2025 12:10:01 UTC
BEIJING, March 21, 2025 /PRNewswire/ --Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leaderAstraZenecato develop potential first-in-class macrocyclic peptides for the treatment of chronic diseases.Under this collaboration,AstraZeneca will gain access toSyneron Bio's innovative Synova platform, an intelligentand high-throughput macrocyclic peptide drug research and development platform, designed to support the advancements of research programmes exploring possible future treatments of chronic diseases,including rare, autoimmune,and metabolic disease.
Published on Fri 21 Mar 2025 12:10:00 UTC
Announced merger agreement with Cullgen in November, anticipated to close in the first half of 2025
Published on Fri 21 Mar 2025 12:09:47 UTC
- Convocatoria final: EIT Jumpstarter 2025 da la bienvenida a innovadores de toda Europa, con especial atencin a los Balcanes, el Mediterrneo y las regiones ultraperifricas de la UE
Published on Fri 21 Mar 2025 12:09:46 UTC
HAYWARD, Calif., March 21, 2025 /PRNewswire/ -- Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal monitoring and assessment based on global clinical practice guidelines, today announced that Todd Dunn, Accuryn's Chief Transformation Officer, will transition to a new role leading the company as Chief Executive Officer. Dunn succeeds Sanjay Banerjee, who is stepping down from his role as CEO.
Published on Fri 21 Mar 2025 12:01:31 UTC
A roundup of the most newsworthy consumer and retail announcements from PR Newswire this week, including PepsiCo's acquisition ofpoppi and a new digital hub from Michaels.
Published on Fri 21 Mar 2025 12:01:27 UTC
MUMBAI, India and Oldenzaal, Netherlands, March 21, 2025 /PRNewswire/ -- Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug Delivery, during the Drug, Chemical and Associated Technologies Association (DCAT) week at New York.
Published on Fri 21 Mar 2025 12:01:24 UTC
MUMBAI, India and Oldenzaal, Netherlands, March 21, 2025 /PRNewswire/ -- Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug Delivery, during the Drug, Chemical and Associated Technologies Association (DCAT) week at New York.
Published on Fri 21 Mar 2025 12:01:21 UTC
GILBERT, Ariz., 21 de marzo de 2025 /PRNewswire-HISPANIC PR WIRE/ -- Recibir atencin mdica de calidad ahora es ms fcil en Gilbert! MY DR NOW est abriendo una nueva clnica de atencin primaria diseada para adaptarse a su horario abierto los siete das de la semana con horario extendido .
Published on Fri 21 Mar 2025 12:01:16 UTC
Bridging the Gap Between Standard Security and Exceptional Service Through Accountability, Integrity, and 24/7 Support
Published on Fri 21 Mar 2025 12:01:13 UTC
- Winners received prestigious award in recognition of their latest innovations in life sciences advancement
Published on Fri 21 Mar 2025 12:01:11 UTC
GILBERT, Ariz., March 21, 2025 /PRNewswire/ -- Getting quality medical care just got easier in Gilbert! MY DR NOW is opening a brand-new primary care clinic designed to fit into your schedule-open seven days a week with extended hours.
Published on Fri 21 Mar 2025 12:01:08 UTC
GILBERT, Ariz., March 21, 2025 /PRNewswire-HISPANIC PR WIRE/ -- Getting quality medical care just got easier in Gilbert! MY DR NOW is opening a brand-new primary care clinic designed to fit into your schedule-open seven days a week with extended hours.
Published on Fri 21 Mar 2025 12:01:06 UTC
ATLANTA, March 21, 2025 /PRNewswire/ --Applications are now being accepted forApolloMD's 2025Emergency Medicine Scholarship for Residents.
Published on Fri 21 Mar 2025 12:00:56 UTC
Join Some of USA's Top Defense Leaders, Innovators, and Businesses April 8-10 in Warren, MI, to Discover Why Michigan is Critical to America's Security and Economic Strength
Published on Fri 21 Mar 2025 12:00:55 UTC
Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b Asset Capable of Combining with Multiple HBV Treatment Modalities for Cure
Published on Fri 21 Mar 2025 12:00:52 UTC
SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, March 21, 2025 /PRNewswire/ -- HarbourBioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in immunology and oncology, today announced a global strategic collaboration with AstraZeneca to discoverand developnext-generation multi-specific antibodies for immunology, oncology and beyond. The strategic collaboration includes an option to license multiple programs utilizing Harbour BioMed's proprietary Harbour Mice fully human antibody technology platform in multiple therapeutic areas and a$105 million equity investment by AstraZeneca in Harbour BioMed.
Published on Fri 21 Mar 2025 12:00:49 UTC
PRINCETON, N.J., March 21, 2025 /PRNewswire/ --Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need,announced today its recent accomplishments and financial results for the year ended December 31, 2024.
Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities